AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Copenhagen Mesenteric Stent Study - A Randomized Trial of Stent Versus Covered Stent Treatment for Chronic Mesenteric Ischemia

RecruitingNAAges 18 Years - anyAllCopenhagen University Hospital, Rigshospitalet
💬

In plain words

What the trial is, and whether it could suit you

Chronic mesenteric ischemia (CMI) is often caused by narrowings in the arteries providing blood to the intestines. Endovascular stent placement is considered the preferred treatment for this condition. Guidelines increasingly support the use of so called covered stents (CS) in stead of bare stents (BMS) for this use but the level of evidence for this is limited. Using CS incur additional costs for healthcare short-term but may prevent recurrence of narrowing and symptoms postoperatively benefitting patients and healthcare. Study Objective: To evaluate the outcomes after stenting of mesenteric arteries using BMS or CS. Study Outcome: Primary stent patency 1 year after placement The trial will also evaluate complications, how often stents need to be reoperated, Quality of Life (QoL) and reasons for subjects death Method: This is a so called prospective, randomized controlled trial c

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Patients with symptomatic CMI of atherosclerotic or atherothrombotic etiology * Intended endovascular treatment * Symptoms consistent with CMI (pain, weight loss, diarrhea) * Significant ostial stenosis (\>50%) of the superior mesenteric artery on CTA * Significant stenosis on angiography (\>50% or \>15mmHg pressure gradient) * Patients \> 18 years Exclusion Criteria: * No informed consent * Non atherosclerotic cause of MI * Acute mesenteric ischemia (AMI) * Signs of acute bowel ischemia, peritonitis, laparotomy, sepsis * Previous stent treatment in the superior mesenteric artery(ies) * Target artery lesions \>4cm in length * Unable to cross lesion with guidewire * Non-significant stenosis angiographically * Pregnancy * Allergies to contrast media or stent materials
💊

What it tests

  • BMS vs. CS
📍

Where

1 site
Department of Vascular Surgery, Heart Center, Copenhagen University Hospital - Rigshospitalet
København Ø, Denmark
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy